Evoke Pharma Inc. held its Annual Meeting on May 21, 2025, via a live webcast. During the meeting, stockholders voted on several proposals. The election of Malcolm R. Hill, Pharm.D., and Vickie W. Reed to the Board of Directors was approved. The appointment of BDO USA, P.C. as the independent auditors for the year ending December 31, 2025, was ratified. The advisory vote on the frequency of future stockholder votes on executive compensation resulted in a recommendation for every three years.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.